Loading...
XTAI
1760
Market cap166mUSD
Jul 09, Last price  
62.20TWD
1D
-2.66%
1Q
-2.81%
Jan 2017
-8.26%
IPO
234.41%
Name

Panion & BF Biotech Inc

Chart & Performance

D1W1MN
XTAI:1760 chart
P/E
28.04
P/S
2.58
EPS
2.22
Div Yield, %
2.89%
Shrs. gr., 5y
1.91%
Rev. gr., 5y
5.64%
Revenues
2.06b
+1.66%
559,396,000524,779,000584,249,000674,896,000857,082,0001,014,406,0001,205,065,0001,049,246,0001,212,478,0001,408,741,0001,573,944,0001,568,637,0001,901,211,0002,398,648,0001,881,875,0002,029,645,0002,063,391,999
Net income
190m
+52.72%
5,088,000-39,305,000-36,260,000-40,562,00018,149,00048,269,00072,996,00089,720,00090,539,000159,171,000161,329,00027,901,000104,402,000182,345,00077,219,000124,523,000190,169,000
CFO
299m
-14.94%
76,978,000-13,895,000-36,120,0003,958,00086,225,00076,111,00058,304,000177,217,000113,973,00078,584,00090,984,000-14,555,000401,225,000489,872,000177,418,000351,188,000298,707,000
Dividend
Jun 12, 20251.8 TWD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Panion & Bf Biotech Inc. is a biopharmaceutical firm operating in Taiwan, engaged in the production and distribution of a diverse range of pharmaceutical goods. Its offerings cater to several key therapeutic and wellness segments, including medical aesthetics, renal care, respiratory health, and gastrointestinal support. Beyond these, the company also provides oral medications, topical treatments, and an array of hygiene products like hand, mechanical, and skin disinfectants, alongside body lotions. Additionally, Panion & Bf Biotech supplies veterinary health solutions, notably surgical and dermatological prescriptions for animals. Established in 1976, the company maintains its corporate headquarters in Taipei, Taiwan.
URL
https://www.pbf.com.tw/
IPO date
Jun 14, 2004
Employees
Domiciled in
TW
Incorporated in
TW

Valuation

Title
TWD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT